NASDAQ:TLSI | Free Cash Flow | TriSalus Life Sciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$6.48M$141,000.00-$6.62M-430.21%
2025-12-31-$2.48M$41,000.00-$2.53M
2025-03-31-$4.5M$754,000.00-$5.25M
2024-12-31-$5.71M$50,000.00-$5.76M
2024-03-31-$10.87M$66,000.00-$10.93M
2023-12-31-$9.18M$372,000.00-$9.55M
2023-03-31-$10.5M$7,000.00-$10.51M
2022-12-31-$8.31M$204,000.00-$8.51M
2022-03-31-$425,954.00
2021-12-31-$680,921.00
2021-03-31-$205,848.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$18.01M$918,000.00-$18.93M
2024-12-31-$40.84M$345,000.00-$41.19M
2023-12-31-$50.58M$588,000.00-$51.17M
2022-12-31-$32.31M$655,000.00-$32.97M
2021-12-31-$1.74M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.